Metabolism and distribution of two highly potent and selective peptidomimetic inhibitors of matriptase

  title={Metabolism and distribution of two highly potent and selective peptidomimetic inhibitors of matriptase},
  author={J. Kotthaus and T. Steinmetzer and D. Schade and A. van de Locht and B. Clement},
  pages={101 - 93}
Matriptase is a serine protease expressed by several types of cancer cells and it participates in tumour growth and progression through the activation of hepatocyte growth factor (HGF) and urokinase-type plasminogen activator (uPA). The metabolism of two potent and selective peptidomimetic inhibitors of matriptase (CJ-1737 and CJ-672) was examined in vitro with enzyme preparations (9000g supernatants, microsomes, and plasma) from dog, pig, rat, and human. It was found that both compounds… Expand
Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2.
The present review will discuss inhibitor design strategy and Structure activity relationships of TTSP inhibitors, which have been reported in the literature. Expand
Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.
The first reported non-peptide small molecule inhibitors of both HGFA and hepsin are discovered, which have differential potency and selectivity towards all three proteases. Expand
The chemical fate of paroxetine metabolites. Dehydration of radicals derived from 4-(4-fluorophenyl)-3-(hydroxymethyl)piperidine.
Four different mechanisms of radical-induced dehydrations have been considered, and the elimination of water from the N-centered radical cation, which results in the formation of an imine intermediate, has been calculated as the most feasible process. Expand
Glycosylation changes leading to the increase in size on the common core of N-glycans, required enzymes, and related cancer-associated proteins
Glycan parts of glycoconjugates on the surfaces of cells regulate many kinds of interactions between the cells and their immediate environments. Alterations in glycosylation on the cancer-associatedExpand


Activation of Hepatocyte Growth Factor and Urokinase/Plasminogen Activator by Matriptase, an Epithelial Membrane Serine Protease*
It is suggested that matriptase could act as an epithelial, upstream membrane activator to recruit and activate stromal-derived downstream effectors important for extracellular matrix degradation and epithelial migration, two major events of tissue remodeling, cancer invasion, and metastasis. Expand
In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
It is concluded that matriptase plays a dual-role in the events unleashing the invasive phenotype, one 'upstream' from the HGF/SF signalling cascade and one 'downstream', most likely at the level of the plasminogen activation system. Expand
Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptase.
Through screening, bis-basic secondary amides of sulfonylated 3-amidinophenylalanine as matriptase inhibitors are identified and molecular modeling revealed that their improved affinity results from interaction with the S4 site of matriptases. Expand
Matriptase and its putative role in cancer
  • K. Uhland
  • Biology, Medicine
  • Cellular and Molecular Life Sciences CMLS
  • 2006
This review summarizes current knowledge about matriptase, its putative role in tumor initiation and progression, and its potential as a novel target in anti-cancer therapy. Expand
Matrix-Degrading Type II Transmembrane Serine Protease Matriptase: Its Role in Cancer Development and Malignancy
In human cancers, malfunction of matriptase potently raises cancer development and metastatic cancer lesions, resulting in activation of the protease, which is correlated with clinical stages. Expand
Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.
This work has shown that cathepsin B as well as plasmin are capable of degrading several components of tumor stroma and may activate zymogens of matrix metalloproteinases, the main family of ECM degrading proteases, which are regulated by a complex array of activators, inhibitors and cellular receptors. Expand
Characterization of cytochrome P450 isoenzymes in primary cultures of pig hepatocytes.
Pigs, apart from their very human-like physiology, might represent a more appropriate model species for oxidative drug metabolism in humans than rats, and the present results indicate the absence of CYP2B and probably CYP 2D enzymes and activities in pig liver. Expand
Comparative Metabolism of Radiolabeled Muraglitazar in Animals and Humans by Quantitative and Qualitative Metabolite Profiling
In conclusion, muraglitazar was rapidly absorbed, extensively metabolized through glucuronidation and oxidation, and mainly eliminated in the feces via biliary excretion of glucuronide metabolites in all species studied. Expand
Species differences in hydrolysis of isocarbacyclin methyl ester (TEI-9090) by blood esterases.
Study of species differences in the hydrolysis of isocarbacyclin methyl ester in whole blood and in its separated components in rats, dogs and human showed that the rat plasma and RBC cytosol esterases hydrolysing TEI-9090 were carboxylesterase (CarbE) and arylesterases (ArE), respectively. Expand
Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species.
  • F. Guengerich
  • Biology, Medicine
  • Chemico-biological interactions
  • 1997
Overall functional similarity is generally seen in subfamily enzymes but many examples exist of important changes in catalysis due to very small differences, even a single conservative amino acid substitution. Expand